Every year 1.35m babies wordwide are born with a congenital heart defect. 400,000 of them suffer from a heart valve defect but currently there is no durable valve replacement available on the market. We are planning to meet that clinical demand with a completely new prosthetic valve for adults and children which is implanted using a low-risk transcatheter technique. Our valve is made from patient-donated (endogenous) tissue, giving it a life-long durability: a once-in-a-lifetime solution that is affordable
GrOwnValve is a pre-clinical stage medical device company, developing a unique heart valve prosthesis system. Our AdultValve and ChildValve are made from the patients‘ own tissue and, including a bioresorbable anchoring device, will be available as part of a procedure pack that enables a safe, affordable and easy-to-use minimally invasive heart valve replacement.
Our aim is to take GrOwnValve from a pre-clinical stage medical device company to an internationally operating medtech company, with the main goal of helping as many patients in need in all regions of the world, banishing heart valve re-operations and lifelong medication.